Compound ID | 1237

Update compound information

ETX0282CPDP (ETX0282 + cefpodoxime)

Class: Beta-lactam (cephalosporin)

Spectrum of activity: Gram-negative
Details of activity: Complicated UTIs (Enterobacteriaceaeincluding ESBL-producing and CRE)
Combined with other compounds: Yes
Institute where first reported: Entasis Therapeutics
Highest developmental phase: Phase 1
Development status: Active
External links:
Guide to Pharmacology: ETX0282
Main Source: https://www.medkoo.com/products/30174
Citations:
  • http://www.entasistx.com/application/files/6815/1846/7209/ODonnell-et-al-ASM-Microbe-2017-SAT-278.pdf
  • http://www.entasistx.com/pipeline

    • AntibioticDB is supported by GARDP.

    If you have feedback, experience problems, or are interested in a collaboration, please contact us.

    Terms and conditions

    The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.